The Burden of Musculoskeletal Disease--a Global Perspective

Overview

Journal Clin Rheumatol

Publisher Springer

Specialty Rheumatology

Date 2006 Apr 13

PMID 16609823

Citations 185

Authors

Peter M Brooks

Affiliations

Soon will be listed here.

Abstract

Musculoskeletal diseases are one of the major causes of disability around the world and have been a significant reason for the development of the Bone and Joint Decade. Rheumatoid arthritis, osteoarthritis and back pain are important causes of disability-adjusted-life years in both the developed and developing world. COPCORD studies in over 17 countries around the world have identified back and knee pain as common in the community and are likely to increase with the ageing population. Musculoskeletal conditions are an enormous cost to the community in economic terms, and these figures emphasise how governments need to invest in the future and look at ways of reducing the burden of musculoskeletal diseases by encouraging exercise and obesity prevention campaigns.

Citing Articles

CRISPR-dCas9 Activation of TSG-6 in MSCs Modulates the Cargo of MSC-Derived Extracellular Vesicles and Attenuates Inflammatory Responses in Human Intervertebral Disc Cells In Vitro.

Martinez-Zalbidea I, Wagner G, Bergendahl N, Mesfin A, Puvanesarajah V, Hitzl W Cell Mol Bioeng. 2025; 18(1):83-98.

PMID: 39949490 PMC: 11813855. DOI: 10.1007/s12195-025-00843-4.

Prevalence and Associated Factors of Musculoskeletal Disorders among Older Patients Treated at Walailak University Physical Therapy Clinic in Thailand: A Retrospective Study.

Rungruangbaiyok C, Vongvaivanichakul P, Lektip C, Sutara W, Jumpathong P, Miyake E Int J Environ Res Public Health. 2024; 21(9).

PMID: 39338136 PMC: 11432095. DOI: 10.3390/ijerph21091253.

Psychologically Informed Physical Therapy Management of Chronic Musculoskeletal Pain in Culturally Diverse Populations: An Intervention Logic Model.

Monroe K, Archer K, Wegener S, Gombatto S J Pain. 2024; 26:104684.

PMID: 39326720 PMC: 11798538. DOI: 10.1016/j.jpain.2024.104684.

Antifibrotic and Pro-regenerative Effects of SMAD3 siRNA and Collagen I mRNA-Loaded Lipid Nanoparticles in Human Tenocytes.

Lopez-Cerda S, Molinaro G, Pareja Tello R, Correia A, Waris E, Hirvonen J ACS Appl Nano Mater. 2024; 7(15):17736-17747.

PMID: 39144399 PMC: 11320386. DOI: 10.1021/acsanm.4c02996.

Study of the Synergistic Immunomodulatory and Antifibrotic Effects of Dual-Loaded Budesonide and Serpine1 siRNA Lipid-Polymer Nanoparticles Targeting Macrophage Dysregulation in Tendinopathy.

Lopez-Cerda S, Molinaro G, Pareja Tello R, Correia A, Kunig S, Steinberger P ACS Appl Mater Interfaces. 2024; 16(15):18643-18657.

PMID: 38564504 PMC: 11040533. DOI: 10.1021/acsami.4c02363.

References

. The burden of musculoskeletal conditions at the start of the new millennium. World Health Organ Tech Rep Ser. 2003; 919:i-x, 1-218, back cover. View

Harkness E, Macfarlane G, Silman A, McBeth J . Is musculoskeletal pain more common now than 40 years ago?: Two population-based cross-sectional studies. Rheumatology (Oxford). 2005; 44(7):890-5. DOI: 10.1093/rheumatology/keh599. View

Chopra A, Saluja M, Patil J, Tandale H . Pain and disability, perceptions and beliefs of a rural Indian population: A WHO-ILAR COPCORD study. WHO-International League of Associations for Rheumatology. Community Oriented Program for Control of Rheumatic Diseases. J Rheumatol. 2002; 29(3):614-21. View

ONeill T . Looking back: developments in our understanding of the occurrence, aetiology and prognosis of osteoporosis over the last 50 years. Rheumatology (Oxford). 2005; 44 Suppl 4:iv33-iv35. DOI: 10.1093/rheumatology/kei059. View

Brooks P . Issues with chronic musculoskeletal pain. Rheumatology (Oxford). 2005; 44(7):831-3. DOI: 10.1093/rheumatology/keh648. View

Chopra A . COPCORD--an unrecognized fountainhead of community rheumatology in developing countries. J Rheumatol. 2004; 31(12):2320-2. View

Zeng Q, Chen R, Xiao Z, Huang S, Liu Y, Xu J . Low prevalence of knee and back pain in southeast China; the Shantou COPCORD study. J Rheumatol. 2004; 31(12):2439-43. View

Gray J . Postmodern medicine. Lancet. 1999; 354(9189):1550-3. DOI: 10.1016/s0140-6736(98)08482-7. View

Mathers C, Vos E, Stevenson C, Begg S . The Australian Burden of Disease Study: measuring the loss of health from diseases, injuries and risk factors. Med J Aust. 2000; 172(12):592-6. DOI: 10.5694/j.1326-5377.2000.tb124125.x. View

10.

Hazes J, Woolf A . The bone and joint decade 2000-2010. J Rheumatol. 2000; 27(1):1-3. View

11.

Darmawan J, VALKENBURG H, Muirden K, Wigley R . Epidemiology of rheumatic diseases in rural and urban populations in Indonesia: a World Health Organisation International League Against Rheumatism COPCORD study, stage I, phase 2. Ann Rheum Dis. 1992; 51(4):525-8. PMC: 1004706. DOI: 10.1136/ard.51.4.525. View

12.

Segal L, Day S, Chapman A, Osborne R . Can we reduce disease burden from osteoarthritis?. Med J Aust. 2004; 180(S5):S11-7. DOI: 10.5694/j.1326-5377.2004.tb05907.x. View

13.

Blyth F, March L, Cousins M . Chronic pain-related disability and use of analgesia and health services in a Sydney community. Med J Aust. 2003; 179(2):84-7. DOI: 10.5694/j.1326-5377.2003.tb05441.x. View

14.

Peltonen M, Lindroos A, Torgerson J . Musculoskeletal pain in the obese: a comparison with a general population and long-term changes after conventional and surgical obesity treatment. Pain. 2003; 104(3):549-557. DOI: 10.1016/S0304-3959(03)00091-5. View

15.

MANAHAN L, Caragay R, Muirden K, Allander E, VALKENBURG H, Wigley R . Rheumatic pain in a Philippine village. A WHO-ILAR COPCORD Study. Rheumatol Int. 1985; 5(4):149-53. DOI: 10.1007/BF00541515. View